SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Cavitation Technologies, Inc. (CVAT) , forward earnings yield 17.57%.
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 5.7
Overall SharesGrow Score: 28/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CVAT
Valuation Multiples
P/E (TTM)0.0
Forward P/E5.7
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio56.10
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Forward EPS (Est.)$0.01
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield17.57%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.00 |
$1.8M |
$432.78K |
24.1% |
| 2017 |
$-0.01 |
$1.06M |
$-1.07M |
-100.4% |
| 2018 |
$0.00 |
$1.3M |
$-250K |
-19.2% |
| 2019 |
$0.00 |
$1.09M |
$-723K |
-66.3% |
| 2020 |
$0.00 |
$1.66M |
$128K |
7.7% |
| 2021 |
$0.00 |
$558K |
$-655K |
-117.4% |
| 2022 |
$0.00 |
$1.67M |
$-934K |
-56.1% |
| 2023 |
$-0.01 |
$433K |
$-2.04M |
-471.1% |
| 2024 |
$0.00 |
$1.36M |
$439K |
32.2% |
| 2025 |
$0.00 |
$203K |
$-113K |
-55.7% |
